CN
110-87-2
应用筛选条件
关键词:'110-87-2'
显示 31-60 共 260 条结果 关于 "110-87-2" 范围 技术文档
Parteck® ODT Excipient: Right here - Right now
+ 1% Mg stearate (500 mg final weight)
(Procedure: USP apparatus 2, 900 ml phosphate buffer, pH 7.2, 37ºC, 50 rpm, 221 nm)
110
100
90
80
70
60
50
40
Data Sheet - R3528
database, accession number
P06400). The sequence is conserved in human, mouse
(80% homology) and rat (87 % homology). The
antiserum is preadsorbed to remove any reactivity with
non-phosphorylated Rb protein
MultiScreen Filter Plates with Ultracel®-10 Membrane
196
FBS 110 97 76 62 62 83 100 112
Human 92 77 61 49 47 64 81 93
10 www.millipore.com
Spin Sample Average Ultrafiltrate Volume (µL) by Row
Time Type A B
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
XV411 or XV421
or XV431 or XV441
87
95
96
97
Applicable for
XV006
86
87
93
97
94
95
96
91
84
90
MultiScreen Solubility Filter Plate: 96-well filter plate designed and optimized for aqueous solubility assays
AUSTRALIA
Tel. 1 800 222 111
or (02) 9888 8999
Fax (02) 9878 0788
AUSTRIA
Tel. 0820 87 44 64
Fax 0820 87 44 44
BALTIC COUNTRIES
Tel. +358 203 05 645
Fax +358 203 05 644
BELGIUM
Tel.
Data Sheet - V6758
vascular endothelial cell mitogen from a rat
glioma-derived cell line. Proc. Natl. Acad. Sci. USA,
87, 1323-1327 (1990).
IDC,KAA,MAM 06/12-1
2012 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA-ALDRICH
Data Sheet - V6883
vascular endothelial cell mitogen from a rat glioma-
derived cell line, Proc. Natl. Acad. Sci. USA, 87,
1323-1327 (1990).
KAA 05/01
Sigma brand products are sold through
Eshmuno®CPS resin
100
110
110
100
120
120
130
130
140
140
150
150
160
160
160170
180
180
170
190
60
60
30
Data Sheet - F8675
amebocyte lysate) method.
References
1. Partanen, J., et al., Proc. Natl. Acad. Sci. USA, 87,
8913 (1990).
2. Givol, D., and Yayon, A., FASEB. J., 6, 3362
(1992).
3. Baird, A., et al.
Product Information Sheet - CKH200A
102
97-107
105
100-113
100
87-109
106
91-115
Average % of Expected 1:8
Range (%)
107
94-121
100
96-109
102
93-107
104
95-110
Process Guidance Cellvento™ CHO-210 medium
Cellvento™ CHO-210 medium. Cells banked
in Cellvento™ CHO-110 medium should be thawed and
maintained in Cellvento™ CHO-110 growth medium
for at least 2 passages prior to sub-culturing in
Cellvento™ CHO-
Process Guidance - Cellvento CHO 210
in Cellvento® CHO-110
medium should be thawed and maintained in Cellvento® CHO-110 growth medium for at least
2 passages prior to sub-culturing in Cellvento® CHO-210 medium.
2. Sequential media adaptation
Product Information Sheet - D8130
P.W. et al., Methods in Enzymology, 91,
49 (1983).
7. Ito, Y. et al., Bioconjugate Chem., 5, 84-87 (1994).
8. Man, M. et al., Anal. Biochem., 57, 429
9. Ming, D. et al., Biotechniques, 18, 808 (1995
Product Information Sheet - S8820
Barrett, A.J. et al., Biochem. J., 201(1), 189-198
(1982).
15. Sugita, H. et al., J. Biochem., 87(1), 339-341
(1980).
16. Katunuma, N. and Kominami, E., Methods
Enzymol., 251, 382-397 (1995).
MultiScreen HTS Glass Fiber Filter Plates
or (02) 9888 8999
Fax (02) 9878 0788
AUSTRIA
Tel. 0820 87 44 64
Fax 0820 87 44 44
BALTIC COUNTRIES
Tel. +358 2 030 5645
Fax +358 2 030 5644
BELGIUM
Tel. 070 225 645
Fax 070 225 644
Product Information Sheet - H3884
dorsal root
ganglia". University of Veterinary Medicine
Hannover, Ph.D. dissertation, pp. 26, 82, 87, 89,
90 (2017).
14. Godinho, Marta Sofia da Conceição, "Investigating
The Role of Elastin in
Product Information Sheet - N0632
for Biochemical
Compounds, 3rd edition. National Academy of
Sciences (Washington, DC), p. 87 (1972).
2. Bergmeyer, Hans-Ulrich, Methods of Enzymatic
Analysis, Volume 4. Academic Press, Inc. (New
Data Sheet - T0440
et al., Sci. Rep., 5, 11431 (2015).
13. Frei, J.C., and Lai, J.R., Methods Enzymol., 580,
45-87 (2016).
14. Gearhart, T.L. et al., J. Immunol. Methods, 435,
85-89 (2016).
15. Thålin, C.
Periodic table Poster
Cs
1
[Xe] 6s1
7
87
*223.02
27
677
0.86
Fr
1
[Rn] 7s1
2
2
3
6.941
180.5
1342
0.97
Li
1
[He] 2s1
4
9.0122
Periodic table A4
Cs
1
[Xe] 6s1
7
87
*223.02
27
677
0.86
Fr
1
[Rn] 7s1
2
2
3
6.941
180.5
1342
0.97
Li
1
[He] 2s1
4
9.0122
Application Note Anaerobic EM using ICR+
C. sporogenes
ATCC 11437
48/49/59
∅ 52 56/52 104 5.5 – 10 N/A N/A
P. acnes ATCC 11827 64/83/87
Ø 78 74/64 89 0.4 1.0 – 1.1 1.5
B. fragilis ATCC 25285 51/59/68
Ø 56
Spare parts for Mobius®Bioreactors (50 L, 200 L, 1000 L & 2000 L)
52
86
1
5
76
50
97
96 87
94
95
76
2
84
78
79
51
3
80
82
4
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
IGHM protein 131 3 87 3
IPI00419424 IGKV1-5 protein 154 2 183 2 171 3 147 2
IPI00719373 IGLC1 protein 202 3
IPI00719452 IGLC1 protein 99 2 81 1 145 2 56 1 100 2 72 1
XP725 Antibody Number-Lot Number 071M4826
1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35
Understanding the Effect of Discreet PEG Linkers on ADC Structure and Binding
100 468 100 392 100
LC-SMCC 4.1 195 87 465 101 309 128
PEG4 4.1 211 80 500 94 299 132
PEG8 4.0 200 84 433 108 358 111
PEG12 3.9 230 74 572 82 361
Product Information Sheet - L6912
voltage-activated calcium channels.” In
Ion Channels, Volume 4 (T. Narahashi, Ed.), pp.
41, 87, Plenum Press, NY (1996).
2. Jentsch, T.J. and Gunther, W., “Chloride channels:
An emerging molecular picture.
Periodensystem der Elemente / Periodic table of Elements
Kr] 5s1
38 87.62 777
1382
0.99Sr
2
[Kr] 5s2
6
55 132.91 28.44
671
0.86Cs
1
[Xe] 6s1
56 137.33 727
1897
0.97Ba
2
[Xe] 6s2
7
87 *223.02 27
Periodic Table of the Elements - Certipur ICP / AAS standards
Xe] 6s1
56 137.33 727
1897
0.97Ba
2
[Xe] 6s2
7
87 *223.02 27
677
0.86Fr
1
[Rn] 7s1
88 *226.03 700
1737
0.97Ra
2
[Rn] 7s2
3 4 5 6 7
Product Information Sheet - CASPASSYRO
5.1 References
1 Alnemri E.S. et al. (1996) Human ICE/CED-3 Protease Nomenclature.
Cell 87, 171.
2 Casciola-Rosen et al. (1996) Apopain/CPP32 Cleaves Proteins That Are
Essential for Cellular Repair
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
. Leukot. Res., 11, 327-332 (1983).
86. Jones, R.L., et al., Br. J. Pharmacol., 96, 875-887 (1989).
87. Morinelli, T.A., et al., J. Pharmacol. Exp. Ther., 251, 557-562 (1989).
88. Armstrong, R.A., et al
2/9